Last reviewed · How we verify

NCT05292482

Pragmatic Randomized Controlled Trial of Pharmacopuncture Therapy for Adhesive Capsulitis : A Pilot Study

Completed NA Last updated 15 June 2023
What this trial tests

NA trial testing pharmacopuncture therapy in Adhesive Capsulitis in 21 participants. Completed in 6 December 2022.

Timeline
20 April 2022
Primary endpoint
25 October 2022
6 December 2022

Quick facts

Lead sponsorJaseng Hospital of Korean Medicine
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment21
Start date20 April 2022
Primary completion25 October 2022
Estimated completion6 December 2022
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Jaseng Hospital of Korean Medicine

Who can join

Adults 19 to 69, any sex, with Adhesive Capsulitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a 2-arm parallel pragmatic randomized controlled trial that will compare pharmacopuncture therapy with physical therapy for adhesive capsulitis.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Pharmacopuncture therapy for adhesive capsulitis: A pragmatic randomized controlled pilot study.
    Kim D, Park KS, Kim SA, Seo JY, et al · · 2024 · cited 2× · PMID 39224580 · DOI 10.1016/j.imr.2024.101065
  2. Economic Evaluation of Pharmacopuncture for Adhesive Capsulitis Alongside a Pilot Pragmatic Randomized Controlled Trial Comparing Pharmacopuncture and Physical Therapy
    Kim D, Park K, Kim S, Seo J, et al · · 2026

Verify or expand the search:

Other trials of pharmacopuncture therapy

Trials testing the same drug.

Other recruiting trials for Adhesive Capsulitis

Currently open trials in the same condition.

Other Jaseng Hospital of Korean Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05292482.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing